Cite
HARVARD Citation
Glaser, N. et al. (2017). Treatment with the KCa3.1 inhibitor TRAM‐34 during diabetic ketoacidosis reduces inflammatory changes in the brain. Pediatric diabetes. 18 (5), pp. 356-366. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Glaser, N. et al. (2017). Treatment with the KCa3.1 inhibitor TRAM‐34 during diabetic ketoacidosis reduces inflammatory changes in the brain. Pediatric diabetes. 18 (5), pp. 356-366. [Online].